Lipid-DNA conjugation is an advanced biochemical technique that covalently links lipophilic molecules with hydrophilic oligonucleotides. This technology combines the membrane-associating properties of lipid molecules with the sequence-specific recognition ability of DNA, resulting in lipid-DNA conjugates that offer biocompatibility, structural controllability, and multifunctionality. Such conjugate systems show significant potential in drug delivery, nanomaterials construction, cellular engineering, and biosensing, representing a key interdisciplinary research direction between life sciences and materials chemistry in recent years.
BOC Sciences is committed to providing comprehensive, customized lipid-DNA conjugation services, integrating advanced chemical modification techniques, high-precision analytical platforms, and GMP-grade production facilities. We can design optimal conjugation strategies for various DNA types (e.g., oligonucleotides, DNA aptamers) and diverse lipid structures, achieving high purity, high conjugation efficiency, and functional self-assembled systems. With extensive R&D experience and full-process project management capabilities, BOC Sciences offers one-stop solutions from conceptual design and experimental development to scalable production, supporting applications in nucleic acid drug delivery, nanomaterials construction, and biosensing.
Lipid-DNA Conjugates Offered by BOC Sciences
Leveraging its integrated technology platform in nucleic acid chemistry and lipid modification, BOC Sciences provides lipid modification services for a wide range of DNA fragments, including but not limited to oligonucleotides, antisense oligonucleotides (ASOs), siRNA fragments, DNA aptamers, circular DNA, modified nucleotide sequences, and functional primers. We support lipid modifications at the 5' end, 3' end, or internal base positions, with multiple conjugation strategies including direct conjugation, PEG spacer linkage, cleavable linkers, and multivalent crosslinked designs. Our team can tailor the most suitable lipid-DNA structures according to project goals—whether enhancing membrane penetration, improving serum stability, or enabling nanostructure assembly and targeted recognition.
Cholesterol-DNA Conjugates
Cholesterol is one of the most commonly used hydrophobic modification groups, effectively enhancing oligonucleotide affinity for cell membranes and transmembrane transport efficiency. BOC Sciences can introduce cholesterol at the 5' end, 3' end, or internal positions of DNA to:
Enhance DNA binding to lipid membranes or nanoparticles;
Improve encapsulation efficiency of genes or siRNA in liposomes, exosomes, and nanomicelles;
Increase plasma stability and circulation half-life of oligonucleotides.
This type is widely used in lipid nanoparticle (LNP) delivery systems, gene-silencing therapeutics, and vaccine adjuvant design.
Phospholipid-DNA Conjugates
Conjugating DNA with natural or synthetic phospholipids generates amphiphilic structures with a balanced hydrophilic–hydrophobic profile. BOC Sciences offers:
Modification systems containing DPPE, DSPE, DOPC, and other phospholipid backbones;
Formation of stable liposomes or DNA-lipid composite membranes;
Support for self-assembly of multiple nucleotide fragments into nanosheets or tubular structures.
These conjugates are widely applied in membrane-mimetic studies, biosensor surface functionalization, and cell membrane-targeted delivery.
PEGylated Lipid-DNA Conjugates
Introducing a polyethylene glycol (PEG) spacer between lipid and DNA allows precise control of spatial configuration and hydrophilicity. BOC Sciences can customize PEG bridging structures based on chain length, functional groups, and density to:
Improve solubility and dispersion of the conjugates;
Reduce nonspecific adsorption and plasma protein binding;
Prolong circulation time in vivo and enhance targeting.
PEGylated lipid-DNA conjugates are particularly suited for long-acting nucleic acid drug delivery systems and stability-enhanced nanosensor design.
Cationic Lipid-DNA Conjugates
By conjugating cationic lipids (e.g., DOTAP, DOTMA, DODAP) with DNA, positively charged complexes are formed, promoting interactions with negatively charged cell membranes. BOC Sciences can customize cationic lipids with different charge densities and carbon chain lengths to achieve:
Efficient intracellular delivery of DNA or mRNA;
Enhanced electrostatic complexation with lipid surfaces;
Controlled membrane fusion and release kinetics.
These conjugates show great potential in gene editing, nucleic acid vaccines, and cell transfection systems.
Fatty Acid-DNA Conjugates
Conjugation of DNA with saturated or unsaturated fatty acids (e.g., palmitic acid, oleic acid, stearic acid) creates molecular interfaces with tunable hydrophobicity. BOC Sciences' fatty acid-DNA products feature:
Modulation of membrane phase behavior based on fatty acid chain length and degree of unsaturation;
Self-assembly into nanomicelles, bilayers, or vesicles;
Compatibility with various nucleic acids (DNA, RNA, aptamers, etc.).
These conjugates are commonly used in DNA nanostructure construction, membrane anchoring studies, and signal amplification systems.
Multivalent Lipid-DNA Conjugates
BOC Sciences can synthesize multivalent structures containing multiple lipid anchoring groups to enhance membrane insertion and stability. Multivalent lipid-DNA conjugates can be used to:
Construct stable lipid-DNA composite networks or biomembrane models;
Design multi-point anchored nanoprobes to increase signal intensity;
Achieve spatially controlled self-assembly of multicomponent nanocomposites.
These structures hold significant value in synthetic biology, nanoelectronics, and controlled drug delivery systems.
Looking for Custom Lipid-DNA Conjugates?
Whether you need small molecule, nucleic acid, peptide, or protein conjugates, our experts can design and deliver optimized solutions for your project.
Expert Lipid-DNA Conjugation Services for Therapeutics and Biosensing
BOC Sciences is dedicated to offering comprehensive support in nucleic acid therapeutics, vaccine development, nanodelivery, and biosensing through advanced lipid-DNA conjugation technology and a globalized custom service system. Leveraging our strengths in chemical design, process development, quality control, and GMP manufacturing, BOC Sciences is becoming the preferred global partner for lipid-DNA conjugation solutions.
Strong R&D Capabilities: Leading lipid-DNA conjugation technology platform covering lipid modification, linker design, and nucleic acid chemistry to ensure conjugation efficiency and structural precision.
Multi-Platform Conjugation Support: Supports solid-phase, solution-phase, and click chemistry strategies, enabling flexible reaction optimization for different DNA sequences and lipid types.
Precision Analysis and QC Systems: Equipped with HPLC, LC-MS, NMR, and other high-precision instruments, providing structural confirmation, purity analysis, and quality tracking reports.
GMP-Grade Production Facilities: GMP-compliant production and purification workshops enable high-quality scale-up from milligram to kilogram levels.
Customized Project Management: Dedicated project managers monitor experimental progress, technical communication, and delivery workflow for efficient project execution.
International Regulatory Compliance: Strict adherence to FDA, EMA, and other international quality standards, offering regulatory guidance and documentation support for drug development and preclinical research.
Global Logistics and Customer Service Network: Worldwide distribution and logistics network ensures efficient delivery, rapid response, and continuous technical support.
Lipid-DNA Conjugation Process: From Design to GMP Production
Requirement Communication and Project Assessment
At the project initiation stage, we conduct in-depth discussions with clients to understand the DNA type (oligonucleotide, siRNA, DNA aptamer, etc.), lipid structure, conjugation site, and downstream application scenarios. Our team evaluates technical feasibility, potential challenges, and estimated timelines, providing preliminary proposals and optimization suggestions to lay the foundation for smooth project progression.
Design Planning and Chemical Strategy Development
Based on the DNA sequence and lipid molecule characteristics provided by the client, our scientific team designs the optimal conjugation route, including the selection of suitable linkers, reaction conditions, and protecting group strategies. We comprehensively consider conjugation efficiency, molecular stability, and bioactivity to ensure that the designed strategy achieves efficient lipid attachment while preserving nucleic acid functionality.
Experimental Synthesis and Process Optimization
In a controlled laboratory environment, BOC Sciences performs lipid-DNA conjugation reactions and optimizes parameters (temperature, solvent, pH, reaction time, etc.) to improve yield and conjugation efficiency. Single trials or small-scale parallel reactions can be conducted as needed to rapidly identify optimal process conditions, providing reliable data for subsequent scale-up production.
Structural Verification and Quality Analysis
After conjugation, the products are thoroughly characterized using HPLC, LC-MS, MALDI-TOF, NMR, and electrophoresis. Analyses include purity assessment, conjugation efficiency, molecular weight confirmation, and stability testing to ensure each batch meets design requirements. A complete analytical report is provided to support clients' research documentation and downstream applications.
Scale-Up Production and GMP Preparation
Upon successful laboratory validation, multi-level scale-up production is performed, including lab-scale, pilot-scale, and commercial GMP manufacturing. BOC Sciences' GMP-compliant facilities allow high-quality preparation from milligrams to kilograms, ensuring batch consistency and traceability, with corresponding quality control documentation and technical support.
Packaging, Delivery, and Ongoing Technical Support
After production, lipid-DNA conjugates are packaged according to client requirements and delivered rapidly through our international logistics network. BOC Sciences also provides ongoing technical support, including stability recommendations, storage guidance, and optimization strategies for experimental or industrial applications, ensuring clients can smoothly advance their research and development.
Interested in Our Custom Lipid Solutions?
Contact our lipid chemistry experts to discuss your project needs.
With their unique amphiphilic structures and chemical modifiability, lipid-DNA conjugates demonstrate broad application potential in biomedicine, nanomaterials, molecular probes, and synthetic biology. Leveraging lipid membrane anchoring and DNA molecular recognition, lipid-DNA conjugates can improve nucleic acid drug delivery efficiency, enable controlled self-assembly, targeted recognition, and smart response functions, providing powerful tools for basic research and applied development.
Nucleic Acid Drug Delivery
Lipid-DNA conjugates significantly enhance the stability and membrane penetration of oligonucleotides, siRNA, and mRNA in vivo. By introducing lipid anchoring groups at DNA ends, the molecules can be incorporated into LNPs, liposomes, or exosome structures, improving intracellular delivery efficiency.
Synthetic Biomembranes and Nanostructures
Lipid-DNA can self-assemble into nanotubes, vesicles, or membrane-like structures, mimicking the physical and chemical properties of natural cell membranes. By precisely designing lipid types and DNA sequences, controlled signal transmission, ion channel simulation, and artificial cell construction are achievable. This self-assembly system provides a stable and tunable functional platform for synthetic biology and nanotechnology.
Molecular Recognition and Biosensing
By modifying lipid surfaces with specific DNA sequences, lipid-DNA conjugates enable highly selective target recognition and response. These systems can be applied in pathogen detection, metal ion sensing, or microenvironment monitoring, and can construct smart responsive biosensors for rapid, precise, and multifunctional analysis.
Cell Adhesion and Membrane Labeling
Lipid-DNA can stably insert into cell membranes, providing specific DNA labeling on the membrane surface while regulating membrane fusion and intercellular communication. This technology offers new tools for cell engineering, tissue regeneration, and cell behavior studies, supporting research on cell interactions, signal transduction, and artificial tissue construction.
Co-delivery of Nanomedicines and Signal Amplification
Lipid-DNA conjugates can integrate multiple functional molecules, including drugs, fluorescent probes, and targeting ligands, to form multifunctional nanocarrier systems. This composite system is applicable for imaging diagnostics, combination therapy, and synergistic drug delivery, while DNA structures amplify signals to enhance detection sensitivity and therapeutic precision.
Stabilization of DNA Nanostructures
Introducing lipid end groups into DNA nanostructures significantly improves stability and structural integrity in biological fluids. Lipid modification enhances resistance to hydrolysis and improves membrane-binding capability, broadening applications of DNA nanomaterials in drug carriers, nanodevices, and bioimaging platforms.
A lipid-DNA conjugate is a molecule in which a lipid moiety is chemically attached to a DNA strand. The conjugation typically involves a covalent bond between a lipid (such as a fatty acid, cholesterol, or phospholipid) and either the 5′ or 3′ end of the DNA.
Key points:
Enhances the hydrophobicity of DNA, improving its interaction with lipid membranes.
Increases cellular uptake and stability of DNA in biological environments.
Often used in drug delivery, gene therapy, nanotechnology, and biosensing applications.
The DNA portion retains its base-pairing properties, while the lipid portion provides membrane anchoring or self-assembly capabilities.
Example: A DNA oligonucleotide conjugated with a cholesterol molecule can insert into cell membranes or liposomes for targeted delivery.
Which types of DNA can be lipid-modified?
We support various DNA types, including oligonucleotides, siRNA, DNA aptamers, circular DNA, and functional primers. Lipid modifications can be applied to the 5' end, 3' end, or internal positions of DNA, with customizable linkers and conjugation strategies.
Is scale-up or GMP production available?
Yes. BOC Sciences has GMP-compliant facilities capable of scaling production from lab milligram scale to pilot and kilogram scale, providing traceable, high-quality lipid-DNA conjugates suitable for research and preclinical development.
How are project timelines and client support ensured?
We provide full-process custom services, including requirement assessment, design planning, experimental synthesis, quality analysis, scale-up production, and delivery. Dedicated project managers oversee the entire process, combined with global logistics and technical support, ensuring on-time delivery and continuous service.
Case Studies and Success Stories
Background
A North American biotechnology research team was developing a novel non-viral gene delivery system. The researchers aimed to introduce lipid anchor groups onto DNA fragments so that the DNA could self-assemble into lipid nanoparticles, improving transmembrane transport efficiency and cellular uptake. Traditional charge-based complexation methods were unstable and prone to altering DNA conformation. Therefore, the client sought covalent conjugation to achieve stable lipid–DNA binding and generate controllable delivery materials.
What Does BOC Sciences Do?
After thoroughly analyzing the client-provided oligonucleotide sequences, BOC Sciences' lipid chemistry team designed a site-directed lipid–DNA conjugation system:
Selected DSPE-PEG-Maleimide as the lipid activation precursor and performed maleimide–thiol reactions to achieve site-specific conjugation with 5'-thiol-modified DNA.
Optimized reaction conditions (pH 7.0 buffer, low ionic strength) to prevent disruption of DNA secondary structures.
Verified structure and purity of the conjugates using HPLC and MALDI-TOF mass spectrometry.
Characterized the self-assembled lipid–DNA nanocomplexes using Dynamic Light Scattering (DLS) and Transmission Electron Microscopy (TEM).
Key Outcomes
Successfully prepared high-purity DSPE-PEG–DNA lipid conjugates with conjugation efficiency over 90%.
The products spontaneously formed uniform nanoparticles (~80–100 nm in diameter).
Conjugated DNA demonstrated significantly enhanced membrane adsorption and intracellular transport in cellular assays.
The client reported that BOC Sciences' conjugation strategy preserved DNA integrity while greatly improving delivery performance, providing a reliable platform for subsequent gene function studies.
Background
A European university laboratory was developing lipid membrane-based surface DNA biosensors to detect specific microRNA molecules. The team planned to anchor DNA probes on the lipid bilayer surface to mimic the cell membrane environment and achieve highly selective recognition. Traditional non-covalent adsorption methods caused probe detachment and poor signal stability. Therefore, the researchers sought lipid-modified DNA probes anchored via lipid tails to enhance detection sensitivity and reproducibility.
What Does BOC Sciences Do?
BOC Sciences provided end-to-end support from lipid design to conjugation validation:
Based on the client's oligonucleotide sequences, selected Cholesterol-TEG-NHS as the lipid derivative and performed NHS ester–amine reactions for conjugation with 5'-amine-modified DNA.
Purified the conjugates by HPLC to remove unreacted components and confirmed conjugation via UV-Vis and mass spectrometry.
Evaluated anchoring behavior of the products in artificial lipid membrane models to ensure stable insertion of the lipid tails.
Delivered the final products in lyophilized form with full quality control and technical reports for direct use in biosensing experiments.
Key Outcomes
Successfully synthesized high-purity Cholesterol–DNA lipid probes with >95% purity.
The conjugates stably inserted into lipid bilayers, significantly enhancing the stability of the sensing interface.
Probes demonstrated higher signal intensity and reproducibility when detecting specific microRNA molecules.
The client reported that BOC Sciences' custom conjugation services greatly shortened experimental optimization time and improved the reliability of the sensing system.
Publications
In our publications section, you can explore the latest research achievements and case studies from global clients who have utilized BOC Sciences' technologies to publish in high-impact journals.
Total synthesis of diazaquinomycins H and J using double Knorr cyclization in the presence of triisopropylsilane. RSC Advances 9.4 (2019): 1759-1771. PMID: 35516148 DOI: 10.1039/c8ra09792e.
Strat-M® synthetic membrane: Permeability comparison to human cadaver skin. International journal of pharmaceutics 547.1 (2018): 432-437. PMID: 29890259 DOI: 10.1016/j.ijpharm.2018.06.012.
The long-chain monounsaturated cetoleic acid improves the efficiency of the n-3 fatty acid metabolic pathway in Atlantic salmon and human HepG2 cells. Br J Nutr. 2019; 122(7): 755-768. DOI: 10.1017/S0007114519001478.
Comprehensive Optimization of a Freeze-Drying Process Achieving Enhanced Long-Term Stability and In Vivo Performance of Lyophilized mRNA-LNPs. Int J Mol Sci. 2024; 25(19): 10603. DOI: 10.3390/ijms251910603.
Osteogenic effects of rapamycin on bone marrow mesenchymal stem cells via inducing autophagy. Journal of Orthopaedic Surgery and Research 18.1 (2023): 129. PMID: 36814286 DOI: 10.1186/s13018-023-03616-9.
Industry Distribution of Custom Lipid Synthesis Clients
"We collaborated with BOC Sciences to synthesize lipid–DNA conjugates for targeted gene delivery. Their team demonstrated outstanding technical expertise, achieving precise control over coupling efficiency and maintaining exceptional product purity."
— Dr. Emily Rogers, Molecular Biologist (United States)
"Our therapeutic program required stable lipid–DNA conjugates for nanoparticle formulation. BOC Sciences provided comprehensive analytical data and excellent scalability, helping us transition from pilot to preclinical production seamlessly."
— Dr. Alexander Weber, CMC Scientist (Germany)
"BOC Sciences delivered a customized lipid–DNA conjugation service that met all of our design criteria. Their chemists were highly responsive and provided valuable insights on linker selection and reaction optimization."
— Ms. Caroline Hughes, Research Scientist (United Kingdom)
"We were impressed by BOC Sciences' capability to handle complex oligonucleotide–lipid conjugation. The resulting conjugates showed remarkable stability in serum and superior performance in cell transfection assays."
— Dr. Matteo Ricci, Nucleic Acid Chemist (Italy)
"Our team worked with BOC Sciences to prepare lipid–DNA conjugates for diagnostic probe development. The products were delivered on time, analytically verified, and performed perfectly in hybridization-based assays."
— Dr. Sophie Dubois, Senior Scientist (France)
"BOC Sciences' lipid–DNA conjugation service greatly accelerated our mRNA delivery research. Their high-quality conjugates showed excellent reproducibility and were accompanied by clear documentation and technical support."
— Dr. Daniel Carter, RNA Therapeutics Researcher (Canada)
We use cookies to understand how you use our site and to improve the overall user experience. This includes personalizing content and advertising.
Read our
Privacy Policy
